AIM ImmunoTech Inc. (AIM)
NYSEAMERICAN: AIM · Real-Time Price · USD
0.140
-0.003 (-1.96%)
At close: Feb 21, 2025, 4:00 PM
0.135
-0.005 (-3.50%)
After-hours: Feb 21, 2025, 7:51 PM EST

AIM ImmunoTech Market Cap

AIM ImmunoTech has a market cap or net worth of $8.82 million as of February 21, 2025. Its market cap has decreased by -58.59% in one year.

Market Cap
8.82M
Enterprise Value
5.02M
1-Year Change
-58.59%
Ranking
Category
Stock Price
$0.14

Market Cap Chart

Since December 1, 1998, AIM ImmunoTech's market cap has decreased from $159.00M to $8.82M, a decrease of -94.45%. That is a compound annual growth rate of -10.43%.

History

DateMarket Cap% Change
Feb 21, 20258.80M-30.16%
Dec 31, 202412.60M-41.40%
Dec 29, 202321.50M43.33%
Dec 30, 202215.00M-65.91%
Dec 31, 202144.00M-39.56%
Dec 31, 202072.80M1,517.78%
Dec 31, 20194.50M-48.28%
Dec 31, 20188.70M-20.91%
Dec 29, 201711.00M-33.73%
Dec 30, 201616.60M-16.58%
Dec 31, 201519.90M-60.20%
Dec 31, 201450.00M12.61%
Dec 31, 201344.40M17.15%
Dec 31, 201237.90M43.56%
Dec 30, 201126.40M-60.42%
Dec 31, 201066.70M-10.23%
Dec 31, 200974.30M166.31%
Dec 31, 200827.90M-50.18%
Dec 31, 200756.00M-59.97%
Dec 29, 2006139.90M19.27%
Dec 30, 2005117.30M24.79%
Dec 31, 200494.00M10.33%
Dec 31, 200385.20M24.74%
Dec 31, 200268.30M-50.29%
Dec 31, 2001137.40M-2.21%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 784.71B
UnitedHealth Group 429.24B
Novo Nordisk 391.83B
Johnson & Johnson 390.76B
AbbVie 356.74B
Abbott Laboratories 234.01B
AstraZeneca 229.50B
Merck & Co. 226.40B
Market Cap Rankings